Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

3,664 public trials 791 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Recruiting

European Real-World Registry for Use of the Ion Endoluminal System

NCT06923774

Conditions
Lung Cancer, Lung Diseases, Lung Neoplasms, +6 more
Locations
  • Hôpital Marie Lannelongue Le Plessis-Robinson, France
  • Helios Klinikum Emil von Behring Berlin, Germany
  • Helios Dr. Horst Schmidt Kliniken Wiesbaden, Germany
  • Universitätsspital Zürich Zurich, Switzerland
View Trial Details
Recruiting

Integrated Cancer Repository for Cancer Research

NCT02012699

Conditions
Abdominal Neoplasms, Adenoma, Adenomatous Polyposis Coli, +195 more
Locations
  • Advent Health Greenwood Village, Colorado, United States
  • Hartford HealthCare Cancer Institute at Manchester Medical Hospital Manchester, Connecticut, United States
  • Florida Hospital Memorial Medical Center Daytona Beach, Florida, United States
  • Florida Hospital DeLand DeLand, Florida, United States
View all 42 locations
View Trial Details
Recruiting

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

NCT07458347

Conditions
Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +44 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Mass General Brigham Cancer Institute at Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Recruiting

GCC 2546- Motion Management

NCT07398209

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States
View Trial Details
Recruiting

Gilteritinib for the Treatment of ALK NSCLC

NCT06225427

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Georgetown University Washington D.C., District of Columbia, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
View Trial Details
Recruiting

Prediction Augmented Screening Initiative

NCT06538636

Conditions
Lung Cancer, Lung Cancer Screening, Lung Diseases, +6 more
Locations
  • VA Bedford HealthCare System, Bedford, MA Bedford, Massachusetts, United States
  • VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA Boston, Massachusetts, United States
  • VA Ann Arbor Healthcare System, Ann Arbor, MI Ann Arbor, Michigan, United States
  • Ralph H. Johnson VA Medical Center, Charleston, SC Charleston, South Carolina, United States
View Trial Details
Recruiting

Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01)

NCT06788912

Conditions
Lung Diseases, Lung Neoplasm Malignant, Lung Neoplasms, +6 more
Locations
  • Southern Cancer Center (SCC) ( Site 8004) Daphne, Alabama, United States
  • Sansum Clinic (Ridley Tree) ( Site 8012) Santa Barbara, California, United States
  • Rocky Mountain Cancer Centers (RMCC) ( Site 8011) Lone Tree, Colorado, United States
  • MedStar Franklin Square Medical Center ( Site 0033) Baltimore, Maryland, United States
View all 38 locations
View Trial Details

Related conditions